Dongjak-gu Seoul, South Korea

Young Seomun


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Hemostasis by Young Seomun

Introduction

Young Seomun, an accomplished inventor based in Dongjak-gu, Seoul, KR, has made significant contributions in the field of medical inventions with his patent related to hemostatic compositions. His innovative approach to addressing issues related to bleeding has garnered attention and support within the medical community.

Latest Patents

Young Seomun holds a notable patent titled "Recombinant batroxobin mixed composition and a hemostatic powder or hemostatic pad comprising same." This patent introduces a novel recombinant batroxobin mixture, which showcases a hemostatic composition designed to effectively manage bleeding. Notably, this composition exhibits an excellent hemostatic effect by suppressing rebleeding, demonstrating its efficacy even when formulated in a solid form. This versatility allows the hemostatic agent to be easily applied topically, making it a valuable tool for various medical applications.

Career Highlights

Seomun is currently associated with Nc Bit Inc., where he works alongside esteemed colleagues like Jong Tak Kim and Jin Woo Kim. His position in a reputed company has enabled him to contribute to critical advancements in medical technology, specifically focusing on improving patient care through innovative hemostatic solutions.

Collaborations

Throughout his career, Young Seomun has collaborated with talented professionals, including his coworkers Jong Tak Kim and Jin Woo Kim. These partnerships are essential in the development and refinement of his inventions, combining expertise across various fields to bring cutting-edge solutions to the market.

Conclusion

Young Seomun's inventive work in developing advanced hemostatic compositions demonstrates his commitment to medical innovation. His contributions, particularly through his patent for a recombinant batroxobin mixture, underscore the potential of his inventions to enhance medical practices. As he continues his work at Nc Bit Inc., the impact of his efforts is likely to resonate within both the scientific and medical communities for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…